DDetect lung cancerDetectCancer.org

Low-dose CT, nodules, PET-CT and biopsy

Lung cancer screening works only for the right risk group and the right follow-up pathway.

Low-dose CT can reduce lung cancer mortality in eligible smokers, but it also finds many nodules that are not cancer. Symptoms still need diagnosis, not a routine screening appointment.

Screening realitySymptoms not to ignoreImmunotherapyVaccines
Educational, not personal medical advice. Coughing blood, persistent cough, unexplained weight loss, chest pain, hoarseness, breathlessness, recurrent pneumonia or a new suspicious nodule needs clinical assessment.
50-80

USPSTF age range for eligible high-risk adults.

20 pack-years

minimum smoking exposure in USPSTF screening criteria.

LDCT

low-dose CT is the screening test, not chest x-ray.

Biopsy

bronchoscopy, EBUS or CT-guided biopsy confirms diagnosis.

Brief outline

Lung cancer includes NSCLC and small cell lung cancer.

Non-small cell lung cancer includes adenocarcinoma, squamous cell carcinoma and large-cell patterns. Small cell lung cancer is usually faster-growing and strongly smoking-related.

CT image of lung adenocarcinoma.
Low-dose CT screening and diagnostic CT both rely on careful nodule interpretation.

Detection frame

Detection has two tracks: screening high-risk smokers with low-dose CT, and diagnostic workup of symptoms or incidental nodules.

Do not ignore

Do not wait if symptoms persist.

Coughing bloodHemoptysis is never a normal screening issue; it needs assessment.
Persistent coughA new or changing cough, especially in a smoker or ex-smoker, deserves review.
Weight loss or fatigueSystemic symptoms with respiratory change are concerning.
HoarsenessCan reflect recurrent laryngeal nerve involvement.
Chest pain or breathlessnessMay reflect tumor, pleural effusion, infection, clot or other disease.
Recurrent pneumoniaRepeated infection in the same area can be caused by an obstructing tumor.

Risk and genetics

Smoking dominates risk, but is not the whole story.

SmokingCurrent and former smoking is the main risk factor; pack-years guide screening eligibility.
RadonImportant household exposure in some regions.
Asbestos and occupational exposureAsbestos, silica, diesel exhaust, arsenic and other exposures add risk.
Air pollutionContributes population risk.
Family historyCan matter, especially with younger or never-smoker lung cancer.
Never-smokersCan develop lung cancer, often adenocarcinoma; symptoms still count.

Screening

Low-dose CT is the evidence-based screening test.

USPSTF recommends annual low-dose CT for adults 50-80 with at least 20 pack-years who currently smoke or quit within 15 years, stopping when risk/fitness changes. Criteria differ by country.

Screening

Low-dose CT

Finds earlier lung cancers in eligible high-risk adults.

Not screening

Chest x-ray

Not recommended for lung cancer screening.

Staging

PET-CT

Assesses metabolic activity and metastatic disease.

Tissue

Bronchoscopy and EBUS

Samples central lesions and lymph nodes.

Tissue

CT-guided biopsy

Useful for peripheral nodules; pneumothorax is a known risk.

Caution

Sputum, breath, saliva and blood tests

Interesting research, not replacements for LDCT in eligible people.

Images, labs and tissue

Nodules need risk-based follow-up, not panic.

CT characterizes size, growth, solid/subsolid pattern and location. PET-CT helps stage or assess larger nodules. Tissue may come from bronchoscopy/EBUS, CT-guided biopsy or surgery.

CT image of lung adenocarcinoma.
Low-dose CT screening and diagnostic CT both rely on careful nodule interpretation.
Lung cancer histology collection.
Tissue diagnosis defines subtype and molecular testing.
Gross pneumonectomy specimen with lung cancer.
Advanced lesions show why early detection matters.

Pros, cons and controversy

LDCT saves lives but creates nodule anxiety.

False positives, incidental findings, radiation, overdiagnosis and downstream biopsies are real. The benefit is strongest when screening stays within high-risk criteria and follows structured nodule protocols.

Lung detection trials ImmunotherapyForLungCancer.com VaccineForLungCancer.com 50Tests.com

Sources and trials

Good starting points.

USPSTF lung screeningUS LDCT screening criteria. NCI lung screening PDQEvidence on low-dose CT, x-ray and harms. ClinicalTrials.gov lung detectionDetection and biomarker trials.